Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
0.851 | 0.080 | 15 | 90085305 | synonymous variant | G/A;C | snv | 3.5E-02; 6.4E-06 |
|
Neoplasms; Respiratory Tract Diseases | 0.020 | 1.000 | 2 | 2017 | 2018 | |||||||
|
0.851 | 0.080 | 15 | 90085305 | synonymous variant | G/A;C | snv | 3.5E-02; 6.4E-06 |
|
Neoplasms; Respiratory Tract Diseases | 0.020 | 1.000 | 2 | 2017 | 2018 | |||||||
|
0.851 | 0.080 | 15 | 90085305 | synonymous variant | G/A;C | snv | 3.5E-02; 6.4E-06 |
|
Neoplasms; Respiratory Tract Diseases | 0.020 | 1.000 | 2 | 2017 | 2018 | |||||||
|
0.851 | 0.080 | 15 | 90085305 | synonymous variant | G/A;C | snv | 3.5E-02; 6.4E-06 |
|
Neoplasms; Respiratory Tract Diseases | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||||
|
0.614 | 0.280 | 15 | 90087472 | missense variant | C/T | snv | 2.0E-03 | 1.6E-03 |
|
Neoplasms | 0.100 | 1.000 | 17 | 2011 | 2019 | ||||||
|
0.614 | 0.280 | 15 | 90087472 | missense variant | C/T | snv | 2.0E-03 | 1.6E-03 |
|
Neoplasms | 0.100 | 0.909 | 11 | 2011 | 2020 | ||||||
|
0.614 | 0.280 | 15 | 90087472 | missense variant | C/T | snv | 2.0E-03 | 1.6E-03 |
|
Neoplasms | 0.080 | 0.875 | 8 | 2013 | 2020 | ||||||
|
0.614 | 0.280 | 15 | 90087472 | missense variant | C/T | snv | 2.0E-03 | 1.6E-03 |
|
Neoplasms | 0.060 | 1.000 | 6 | 2013 | 2017 | ||||||
|
0.614 | 0.280 | 15 | 90087472 | missense variant | C/T | snv | 2.0E-03 | 1.6E-03 |
|
Neoplasms | 0.060 | 1.000 | 6 | 2013 | 2017 | ||||||
|
0.614 | 0.280 | 15 | 90087472 | missense variant | C/T | snv | 2.0E-03 | 1.6E-03 |
|
Neoplasms | 0.050 | 1.000 | 5 | 2014 | 2019 | ||||||
|
0.614 | 0.280 | 15 | 90087472 | missense variant | C/T | snv | 2.0E-03 | 1.6E-03 |
|
Neoplasms | 0.050 | 0.800 | 5 | 2013 | 2017 | ||||||
|
0.614 | 0.280 | 15 | 90087472 | missense variant | C/T | snv | 2.0E-03 | 1.6E-03 |
|
Neoplasms | 0.050 | 0.800 | 5 | 2013 | 2017 | ||||||
|
0.614 | 0.280 | 15 | 90087472 | missense variant | C/T | snv | 2.0E-03 | 1.6E-03 |
|
Neoplasms | 0.040 | 1.000 | 4 | 2015 | 2020 | ||||||
|
0.614 | 0.280 | 15 | 90087472 | missense variant | C/T | snv | 2.0E-03 | 1.6E-03 |
|
Neoplasms | 0.030 | 1.000 | 3 | 2013 | 2016 | ||||||
|
0.614 | 0.280 | 15 | 90087472 | missense variant | C/T | snv | 2.0E-03 | 1.6E-03 |
|
Neoplasms | 0.030 | 0.667 | 3 | 2015 | 2018 | ||||||
|
0.614 | 0.280 | 15 | 90087472 | missense variant | C/T | snv | 2.0E-03 | 1.6E-03 |
|
Neoplasms | 0.030 | 1.000 | 3 | 2013 | 2016 | ||||||
|
0.614 | 0.280 | 15 | 90087472 | missense variant | C/T | snv | 2.0E-03 | 1.6E-03 |
|
Neoplasms | 0.020 | 1.000 | 2 | 2016 | 2017 | ||||||
|
0.614 | 0.280 | 15 | 90087472 | missense variant | C/T | snv | 2.0E-03 | 1.6E-03 |
|
Neoplasms | 0.020 | 1.000 | 2 | 2015 | 2018 | ||||||
|
0.614 | 0.280 | 15 | 90087472 | missense variant | C/T | snv | 2.0E-03 | 1.6E-03 |
|
Neoplasms | 0.020 | 1.000 | 2 | 2016 | 2017 | ||||||
|
0.614 | 0.280 | 15 | 90087472 | missense variant | C/T | snv | 2.0E-03 | 1.6E-03 |
|
Neoplasms | 0.020 | 1.000 | 2 | 2012 | 2015 | ||||||
|
0.614 | 0.280 | 15 | 90087472 | missense variant | C/T | snv | 2.0E-03 | 1.6E-03 |
|
0.020 | 1.000 | 2 | 2015 | 2016 | |||||||
|
0.614 | 0.280 | 15 | 90087472 | missense variant | C/T | snv | 2.0E-03 | 1.6E-03 |
|
Neoplasms | 0.020 | 1.000 | 2 | 2015 | 2016 | ||||||
|
0.614 | 0.280 | 15 | 90087472 | missense variant | C/T | snv | 2.0E-03 | 1.6E-03 |
|
Neoplasms | 0.020 | 1.000 | 2 | 2012 | 2015 | ||||||
|
0.614 | 0.280 | 15 | 90087472 | missense variant | C/T | snv | 2.0E-03 | 1.6E-03 |
|
Neoplasms | 0.020 | 1.000 | 2 | 2016 | 2018 | ||||||
|
0.614 | 0.280 | 15 | 90087472 | missense variant | C/T | snv | 2.0E-03 | 1.6E-03 |
|
Neoplasms; Nervous System Diseases | 0.020 | 1.000 | 2 | 2011 | 2017 |